Efficacy and Endocrine Effects of Medical Treatment of Endometriosis

G. B. Melis, Melis GB, Gian Benedetto Melis, V MAIS, Mais V, Valerio Mais, A M Paoletti, Paoletti AM, Anna Maria Paoletti, S. Ajossa, Ajossa S, Guerriero S, S. Guerriero, Fioretti P, P. Fioretti
Annals of the New York Academy of Sciences · 1991 · vol. 622(1) , pp. 275–282 · doi:10.1111/j.1749-6632.1991.tb37871.x · PMID:1829594 · W2062578064
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This paper investigates the efficacy and endocrine effects of medical treatments for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Buserelin Danazol Endometriosis Gestrinone Hypothalamus Pituitary Gland Adolescent Adult Buserelin Buserelin Danazol Danazol Endometriosis Endometriosis Endometriosis Female Follicle Stimulating Hormone Follicle Stimulating Hormone Gestrinone Gestrinone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (2)

Source provenance

europepmc
last seen: 2026-09-12T06:55:35.949492+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:05.481982+00:00
unpaywall
last seen: 2026-09-12T07:21:10.926195+00:00
License: CC0 · commercial use OK